Table 7. Management Status of Hypercholesterolemia during the Most Recent 10 Years.
| Variable | 2005 (third KNHANES) | 2007–2009 (fourth KNHANES) | 2010–2012 (fifth KNHANES) | 2013–2015 (sixth KNHANES) |
|---|---|---|---|---|
| Awarenessa | ||||
| Total | 24.0±2.4 | 38.8±1.5 | 47.4±1.4 | 57.7±1.3 |
| Male | 24.4±4.2 | 37.0±2.2 | 45.2±2.3 | 51.4±2.0 |
| Female | 23.8±3.0 | 40.3±1.8 | 49.1±1.7 | 62.4±1.6 |
| Treatmentb | ||||
| Total | 17.3±2.1 | 26.9±1.3 | 37.3±1.4 | 45.5±1.3 |
| Male | 17.5±3.6 | 24.6±1.9 | 35.8±2.0 | 39.8±2.0 |
| Female | 17.1±2.6 | 28.6±1.6 | 38.4±1.8 | 49.9±1.6 |
| Rate of control (in those with hypercholesterolemia)c | ||||
| Total | 10.8±1.7 | 20.3±1.1 | 29.9±1.2 | 39.7±1.2 |
| Male | 11.0±2.5 | 20.2±1.7 | 28.7±1.8 | 37.1±1.9 |
| Female | 10.6±2.2 | 20.3±1.4 | 30.9±1.6 | 41.7±1.5 |
| Rate of control (in the treated)d | ||||
| Total | 62.3±6.6 | 73.5±2.2 | 78.8±1.6 | 84.3±1.2 |
| Male | 63.1±11.0 | 80.6±3.3 | 79.3±2.8 | 88.4±1.8 |
| Female | 61.8±7.9 | 68.8±2.9 | 78.5±1.9 | 81.8±1.6 |
Values are expressed as mean±standard error.
KNHANES, Korean National Health and Nutrition Examination Survey.
aAwareness: proportion of the population diagnosed by a doctor; bTreatment: proportion of the population taking a lipid-lowering medication ≥20 days a month; cRate of control (in those with hypercholesterolemia): proportion of the population with hypercholesterolemia with a serum total cholesterol level <200 mg/dL; dRate of control (in the treated): proportion of the population with a serum total cholesterol level <200 mg/dL among those treated with lipid-lowering medications.